"Tirzepatide is an Imbalanced and Biased Dual GIP and GLP-1 Receptor Agonist." JCI Insight, 2020, 5(17), e140532
Threading through all of these complications is one quiet constant: glutathione depletion
Food choices abroad can trigger nausea if meals are heavy, greasy, or larger than portions your GLP-1 therapy has conditioned your body to handle
To ensure safety and compliance in drug compounding, you should: Confirm the pharmacy only uses semaglutide base API, not salt forms
In a controlled trial, participants who consumed 12.5g of allulose showed higher GLP-1 levels and reduced hunger compared to a placebo group
The largest clinical trials in people with type 1 diabetes were conducted with liraglutide and showed decreases in HbA 1c at daily doses of 1.8 mg (0.20.4% [24 mmol/mol]), decreases in weight (~5 kg) and reductions in insulin doses [257, 258]